The company is led by the former CEO of one of Jacksonville's fastest-growing companies of the past.
A biopharmaceutical startup led by the former CEO of one Jacksonville's fastest-growing companies debuted on the Nasdaq stock exchange on Friday, priced at $5 a share.
The drug being developed by Cadrenal is an oral anti-coagulant that Pham has previously said could replace warfarin as a standard medication. The company is looking to sell 1.4 million shares of stock, raising $7 million before expenses. Various existing shareholders, including the Boys & Girls Club of Northeast Florida, are expected to sell another 1.7 million shares.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Jacksonville hospitals ranked among best in U.S. by Healthgrades - Jacksonville Business JournalMayo Clinic and a pair of HCA facilities made the exclusive list.
Weiterlesen »
Mark Cuban on disrupting the pharmaceutical industry - CEO SpotlightMark Cuban, CEO of Cuban Companies, joins David Johnson on this episode of CEO Spotlight.
Weiterlesen »
Study: Florida among states with most new home builds - Jacksonville Business JournalUtah is the state with the most new construction homes being developed, with 11.7 new builds per 1,000 residents.
Weiterlesen »
JSO report details what led to arrest of man charged in North Jacksonville triple murderAn arrest report obtained Wednesday by News4JAX reveals new information in the arrest of Ja-Darrius Jones, the man who faces charges of second-degree murder in the deaths of three people whose bodies were found by Jacksonville police inside a home on the Northside.
Weiterlesen »
‘It took off:’ Jacksonville print shop working nonstop ahead of Jaguars @ ChiefsNot surprisingly, retailers have seen a boost in Jaguars merchandise sales following the team’s turnaround worst-to-first season.
Weiterlesen »